STAT delivers trusted and authoritative journalism about health, medicine, and the life sciences. Millions of new readers turned to us as we sounded the alarm early on about the Covid-19 pandemic. Our journalists go deep in tough-minded coverage of the business of making medicines, health tech, science, and public health.
We take you inside academic labs, biotech boardrooms, and political backrooms. We cast a critical eye on scientific discoveries, scrutinize corporate strategies, and chronicle roiling battles for talent, money, and market share. We examine controversies and puncture hype. With an award-winning newsroom, STAT gives you indispensable insights and exclusive stories on the technologies, personalities, power brokers, and political forces driving massive changes in the life science industry — and a revolution in human health. These are the stories that matter to us all.
Boston • Washington • New York • San Francisco • Los Angeles • Cleveland • Minneapolis
What’s STAT all about?
STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features, podcasts, and opinion pieces. We tell our stories from the places that matter to our readers — research labs, hospitals, executive suites, and political campaigns.
Why did you call it STAT?
In medical parlance, “stat” means important and urgent, and that’s what we’re all about — quickly and smartly delivering good stories. Read more about the origins of our name here.
Who’s behind the publication?
STAT is produced by Boston Globe Media. Our headquarters is in Boston but we have journalists across the country and also cover international stories. It was launched in November 2015 by John Henry, the owner of Boston Globe Media and the principal owner of the Boston Red Sox. Rick Berke is the co-founder and executive editor. Here’s Mr. Henry’s article, “Why I started STAT.’’
So is STAT part of The Boston Globe?
No. They’re distinct publications with separate staffs, but the two share some content and complement one another.
Is it free?
Many STAT stories are free. We also offer STAT+, a premium subscription plan that includes exclusive reporting about the pharmaceutical and biotech industries, the health tech industry, science, and coverage at the intersection of health and policy, as well as access to exclusive events and other benefits. Learn more about it here.
Who’s working for STAT?
Some of the best-sourced science, health, and biotech journalists in the country, as well as motion graphics artists, videographers, and podcast producers. Our team includes talented writers, editors, and producers capable of the kind of explanatory journalism that complicated science issues demand.
Who’s your audience?
You. Even if you don’t work in science, have never stepped foot in a hospital, or hated high school biology, we’ve got something for you. And for the lab scientists, health professionals, business leaders, and policy makers, we think you’ll find must-read coverage here. The world of health, science, and medicine is booming and yielding fascinating stories. We explore how they affect us all.
How often is the site updated?
We’ve created a thriving news site and publish content throughout the day. We have daily newsletters, including our flagship newsletter Morning Rounds and our national biotech blast, The Readout. Sign up for our newsletters here.
How will I be able to keep up with STAT’s coverage?
Visit our site, and visit often. If you like what you read, we have a plethora of free newsletters you can sign up for based on the topics that are most interesting to you. And you can also follow us on Facebook, on Twitter/Instagram @statnews, and on LinkedIn.